EAM
IRON icon

Exome Asset Management’s Disc Medicine IRON Stock Holding History

Exome Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,743
Closed -$3.71M – 69
2025
Q4 		$3.71M Sell
46,743
-14,613
-24% -$1.23M 1.77% 18
2025
Q3 		$4.05M Hold
61,356
– – 2.46% 11
2025
Q2 		$3.25M Sell
61,356
-300
-0.5% -$14.1K 2.42% 14
2025
Q1 		$3.06M Sell
61,656
-7,416
-11% -$412K 2.72% 13
2024
Q4 		$4.38M Buy
69,072
+4,556
+7% +$264K 3.29% 7
2024
Q3 		$3.17M Buy
64,516
+3,516
+6% +$165K 2.14% 18
2024
Q2 		$2.75M Buy
+61,000
New +$2.07M 2.45% 16

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Exome Asset Management's IRON Position: Q1 2026 in Review

Exome Asset Management sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 46,743 shares — an estimated $3.71M sold.

Exome Asset Management first reported a position in IRON in Q2 2024 and held it in 7 quarters. The position peaked at $4.38M in Q4 2024. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Exome Asset Management reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
  • Exome Asset Management sold 46,743 Disc Medicine shares in Q1 2026, an estimated $3.71M.
  • Exome Asset Management first reported a position in Disc Medicine in Q2 2024 and held it in 7 quarters.
  • Exome Asset Management's Disc Medicine position peaked at $4.38M in Q4 2024.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.